PROTALIX BIOTHERAPEUTICS INC's ticker is and the CUSIP is 74365AAB7. A total of 12 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $7,664,000,000 | -2.3% | 11,000,000 | 0.0% | 0.11% | -32.5% |
| Q2 2016 | $7,844,000,000 | -2.2% | 11,000,000 | 0.0% | 0.17% | +15.0% |
| Q1 2016 | $8,021,000,000 | -0.6% | 11,000,000 | 0.0% | 0.15% | +8.1% |
| Q4 2015 | $8,070,000,000 | +8.6% | 11,000,000 | +10.0% | 0.14% | -9.9% |
| Q3 2015 | $7,430,000,000 | -6.3% | 10,000,000 | 0.0% | 0.15% | +9.4% |
| Q2 2015 | $7,929,000,000 | -8.0% | 10,000,000 | -9.1% | 0.14% | -25.0% |
| Q1 2015 | $8,619,000,000 | -0.2% | 11,000,000 | 0.0% | 0.18% | +22.7% |
| Q4 2014 | $8,635,000,000 | – | 11,000,000 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|